On September 6, 2024, Invivyd, Inc., a biotechnology company, disclosed the posting of an updated corporate presentation on its website. The presentation, which provides current information about the company's operations and strategy, is now accessible to the public and investors. This update was formally reported in a Form 8-K filing with the United States Securities and Exchange Commission. The document, identified as Exhibit 99.1, has been incorporated by reference into the filing, ensuring that it forms part of the official record. Invivyd, which is listed on The Nasdaq Stock Market under the trading symbol IVVD, is classified as an emerging growth company. The company's principal executive offices are located at 1601 Trapelo Road, Suite 178, Waltham, MA 02451.

On September 6, 2024, Invivyd, Inc., a biotechnology company, disclosed the posting of an updated corporate presentation on its website. The presentation, which provides current information about the company's operations and strategy, is now accessible to the public and investors. This update was formally reported in a Form 8-K filing with the United States Securities and Exchange Commission. The document, identified as Exhibit 99.1, has been incorporated by reference into the filing, ensuring that it forms part of the official record. Invivyd, which is listed on The Nasdaq Stock Market under the trading symbol IVVD, is classified as an emerging growth company. The company's principal executive offices are located at 1601 Trapelo Road, Suite 178, Waltham, MA 02451.